X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs PFIZER - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD PFIZER ORCHID PHARMA LTD/
PFIZER
 
P/E (TTM) x -0.6 28.9 - View Chart
P/BV x 0.4 4.6 9.6% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 ORCHID PHARMA LTD   PFIZER
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
PFIZER
Mar-16
ORCHID PHARMA LTD/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1942,724 7.1%   
Low Rs351,611 2.2%   
Sales per share (Unadj.) Rs276.5440.9 62.7%  
Earnings per share (Unadj.) Rs-79.248.7 -162.7%  
Cash flow per share (Unadj.) Rs-43.575.8 -57.3%  
Dividends per share (Unadj.) Rs015.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs53.9462.9 11.7%  
Shares outstanding (eoy) m70.4545.75 154.0%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.44.9 8.4%   
Avg P/E ratio x-1.444.5 -3.2%  
P/CF ratio (eoy) x-2.628.6 -9.2%  
Price / Book Value ratio x2.14.7 45.3%  
Dividend payout %030.8 0.0%   
Avg Mkt Cap Rs m8,06799,163 8.1%   
No. of employees `0002.82.9 96.9%   
Total wages/salary Rs m2,5272,758 91.6%   
Avg. sales/employee Rs Th6,956.16,981.7 99.6%   
Avg. wages/employee Rs Th902.5954.5 94.6%   
Avg. net profit/employee Rs Th-1,993.0771.1 -258.5%   
INCOME DATA
Net Sales Rs m19,47720,170 96.6%  
Other income Rs m407857 47.5%   
Total revenues Rs m19,88421,028 94.6%   
Gross profit Rs m1,1034,310 25.6%  
Depreciation Rs m2,5191,239 203.4%   
Interest Rs m5,2275 100,515.4%   
Profit before tax Rs m-6,2363,923 -159.0%   
Minority Interest Rs m200-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m51199 516.8%   
Tax Rs m-1251,794 -7.0%   
Profit after tax Rs m-5,5802,228 -250.5%  
Gross profit margin %5.721.4 26.5%  
Effective tax rate %2.045.7 4.4%   
Net profit margin %-28.711.0 -259.4%  
BALANCE SHEET DATA
Current assets Rs m11,01416,299 67.6%   
Current liabilities Rs m32,0607,594 422.2%   
Net working cap to sales %-108.143.2 -250.4%  
Current ratio x0.32.1 16.0%  
Inventory Days Days9565 145.4%  
Debtors Days Days3426 130.3%  
Net fixed assets Rs m29,4408,622 341.5%   
Share capital Rs m705458 154.0%   
"Free" reserves Rs m2,04320,722 9.9%   
Net worth Rs m3,80021,180 17.9%   
Long term debt Rs m9,01825 36,071.6%   
Total assets Rs m46,51029,137 159.6%  
Interest coverage x-0.2755.5 -0.0%   
Debt to equity ratio x2.40 201,056.0%  
Sales to assets ratio x0.40.7 60.5%   
Return on assets %-0.87.7 -9.9%  
Return on equity %-146.910.5 -1,396.2%  
Return on capital %-3.719.0 -19.7%  
Exports to sales %37.90.1 63,668.0%   
Imports to sales %22.617.5 129.4%   
Exports (fob) Rs m7,37812 61,480.0%   
Imports (cif) Rs m4,4063,526 125.0%   
Fx inflow Rs m7,51352 14,546.6%   
Fx outflow Rs m5,649140 4,035.4%   
Net fx Rs m1,865-88 -2,110.8%   
CASH FLOW
From Operations Rs m1,6823,436 48.9%  
From Investments Rs m-9,860-6,991 141.0%  
From Financial Activity Rs m6,644-619 -1,073.7%  
Net Cashflow Rs m-1,535-4,174 36.8%  

Share Holding

Indian Promoters % 32.3 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 4.6 7.5 61.3%  
FIIs % 3.3 4.9 67.3%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 23.7 233.3%  
Shareholders   84,811 85,207 99.5%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   MERCK LTD  STERLING BIOTECH  JUBILANT LIFE SCIENCES  VENUS REMEDIES  IPCA LABS  

Compare ORCHID PHARMA LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Power Stocks Top Losers(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jan 19, 2018 02:53 PM

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD 8-QTR ANALYSIS

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS